02Nov2026
Highlight content / Highlight Content JP / Highlight content vi / Industry Reviews / Latest News & Report
Comments: No Comments.
Vietnam is emerging as a promising medical tourism market, with around 300,000 international users of medical services and annual spending of USD 1–2 billion, while Vietnamese patients continue to spend USD 2–3 billion on treatment abroad. [1] Despite advanced clinical capabilities and cost advantages, the market still lacks consistent quality standardization and an integrated service chain spanning treatment, recovery, accommodation and post-treatment care. This gap creates opportunities for Japanese companies to contribute strengths in quality management, patient coordination, rehabilitation, elderly care and medical accommodation, serving both international patients and the domestic premium segment.

Source: VnEconomy
Market Context & Paradox
Two Opposing Flows of Spending
According to figures cited by the Ministry of Health in 2026, Vietnam receives around 300,000 international users of medical services each year, with estimated total spending of USD 1–2 billion; Ho Chi Minh City accounts for roughly 40%. In the opposite direction, Vietnamese patients continue to spend approximately USD 2–3 billion annually on medical treatment abroad. [1] This disparity suggests that Vietnam has already gained some traction among international patients, but has yet to fully meet the needs of high-spending domestic customers, particularly in terms of standardized quality, trust, and service experience.
Clinical capabilities exist, but the international service chain remains incomplete
The gap does not stem entirely from clinical capacity. In 2025, Vietnam had 2,107 hospitals, more than 339,000 hospital beds, over 105,000 doctors and 103 specialized hospitals, including 13 high-tech hospitals. International patients have already used services including dentistry, cosmetic procedures, assisted reproduction, general health screening and selected advanced treatments. [1]
The key issue is that clinical capabilities have not yet been connected into a service journey that fully meets the expectations of international patients and premium customers. Beyond medical expertise, these groups require transparent and verifiable treatment outcomes, multilingual processes, insurance and direct-billing support, post-discharge coordination, and appropriate accommodation and rehabilitation services.
The gap between existing clinical capabilities and an incomplete service chain creates an entry point for Japanese companies. Rather than competing directly on treatment or price, Japanese providers can add capabilities in quality standardization, patient coordination, rehabilitation and medical accommodation, thereby serving both international patients and Vietnamese customers currently seeking premium care overseas.
Clinical Capabilities & System Bottlenecks
Mini Case Studies: Clinical Capabilities Are in Place, but the Patient Journey Remains Fragmented
Binh Dan Hospital – Urethral Reconstruction
In 2025, Binh Dan Hospital successfully operated on an American patient who had suffered from urethral stricture for 15 years after six unsuccessful surgeries in several countries. The hospital reported a 98% success rate for urethral reconstruction and treated 1,096 patients from 26 countries during 2023–2025. [8] The case demonstrates that some of Vietnam’s highly specialized services can attract international patients, but it also highlights a post-operative gap: where should patients and accompanying family members stay during one to three weeks of follow-up when conventional hotels do not provide medical beds, wound-care nursing, or appropriate post-operative nutrition and rehabilitation?
Tu Du Hospital – Children’s Hospital 1: Fetal Cardiac Intervention
In May 2025, the two hospitals jointly performed a successful fetal cardiac intervention for a Singaporean patient referred to Ho Chi Minh City because the procedure was not available in Singapore. This was the ninth case under the program and involved a highly complex technique. [9] The case points to the potential for an international referral network for advanced procedures, while also highlighting the need for cross-border coordination: medical records and treatment results must be transferred securely to physicians in Singapore for continued pregnancy monitoring.
Robotic Surgery for Cancer Treatment
Robotic surgery is already used in Vietnam in specialties including urology, gastrointestinal surgery and oncology. In 2026, a facility in Ho Chi Minh City reported that surgery using the Da Vinci Xi system cost approximately USD 5,000–7,000, equivalent to about 30% of the cost of treatment abroad using the same technology; actual fees vary by hospital, procedure and treatment package. [10] The combination of technical capability and cost competitiveness may attract international patients, but, as with urethral reconstruction, medical accommodation, nursing, rehabilitation, complication management and follow-up after patients return home still need to be integrated into the treatment pathway.
The three cases indicate that Vietnam has developed notable capabilities in the “operating room,” while the broader journey — pre-admission, accommodation/recovery, post-discharge care and cross-border follow-up — has yet to be connected into a complete service chain. This creates opportunities for Japanese healthcare and hospitality companies to develop medical hotels/recovery residences, post-treatment nursing and rehabilitation, case management, concierge services and cross-border health-data connectivity.
Three System Bottlenecks to Address
Bottleneck 1 – Quality Standardization and Transparency
The level of international standardization and transparency of treatment outcomes remains uneven across healthcare facilities in Vietnam. International patients and premium customers look beyond physicians’ expertise to verifiable standards for patient safety, infection control, nursing, treatment outcomes, complications, and readmissions. [1][2] This creates a market entry point for Japanese companies through partnerships with Vietnamese hospitals to standardize multilingual SOPs, conduct quality audits, establish outcome KPIs, train nurses and strengthen patient-safety management, rather than necessarily investing in a new healthcare facility.
One operating precedent is T-Matsuoka Medical Center in Hanoi. The center provides Ningen Dock health screening based on Japanese processes and service inspired by the Omotenashi philosophy, while connecting diagnostic imaging with three centers in Japan for Japanese specialists to read or cross-check CT, MRI and other imaging results. [11] The model demonstrates that importing Japanese operating standards, service practices and remote clinical expertise into a Vietnam-based facility is already a practical precedent rather than merely a proposed concept.
Bottleneck 2 – A Fragmented Patient Journey
The international patient journey is not yet seamlessly connected across hospitals, accommodation, transport, insurance, rehabilitation and post-operative care. Although Ho Chi Minh City has developed a number of medical-tourism products, the tourism sector continues to emphasize the need for stronger linkages and a more complete service ecosystem. [3] The gap is particularly visible in the Binh Dan and robotic-surgery cases: after treatment, patients may require another one to three weeks of monitoring, while conventional hotels are not designed for post-operative care. This creates opportunities for medical hotels/recovery residences, case managers, concierge services, hospital–hotel packages and 7–28-day rehabilitation programs.
Bottleneck 3 – Regulation and Cross-Border Data
For international patients, compliance requirements extend beyond medical-service licensing to include scope of practice, language/interpreting requirements, professional liability and personal-data protection. [4][5] The fetal cardiac intervention for the Singaporean patient directly illustrates the need to transfer medical records and treatment results securely to physicians in the patient’s home country for continued follow-up. Japanese companies can reduce market-entry risk through asset-light partnerships or joint ventures (JVs) with Vietnamese healthcare legal entities, while applying privacy-by-design principles and consent-based medical-record sharing.
Collaboration Opportunities Across Three Integrated Healthcare and Hospitality Pillars
The three pillars below are built around one principle: Japanese companies do not need to own an entire hospital to participate in the market. Value can be created by adding capabilities that the current system lacks and connecting them with Vietnam’s existing clinical capacity and accommodation infrastructure.
Three Pillars of Healthcare and Hospitality Integration
| Pillar | Primary customers | Need / gap | Specific product / entry point | Revenue model | Priority locations |
| 1. Standardize & Navigate | Expatriates/foreign professionals in Vietnam; premium domestic customers, particularly those inclined to seek treatment abroad; B2B corporate clients | Need for local healthcare services with verifiable standards, processes and quality, reducing the need to travel abroad for treatment/screening | Japanese-style health screening; Japan Desk; case management; Japan–Vietnam second opinion; quality-management-as-a-service; insurance/direct-billing support. | Management fees; per-case fees; annual B2B contracts; protocol licensing; revenue share | Ho Chi Minh City, Hanoi; followed by Hai Phong and Da Nang. |
| 2. Recover & Stay | Inbound medical tourists and overseas Vietnamese, particularly patients requiring 7–28 days of accommodation after surgery, IVF or complex dental treatment | Gap between hospital discharge and full recovery; shortage of accommodation with nursing, rehabilitation and hospital connectivity | Medical hotel/recovery residence for 7–28 days; physio/rehab; prescribed nutrition; caregiver room; shuttle; telemedicine; hospital–hotel bundle | Premium room-night revenue; recovery packages; hospital–hotel bundles; nursing/physio services within licensed scope | Ho Chi Minh City–Ba Ria/Vung Tau; Da Nang–Hue; Nha Trang/Khanh Hoa. |
| 3. Age & Prevent | Domestic elderly population and Silver Tourism/Long-stay customers from developed markets | Growing long-term care, prevention and rehabilitation needs as the population ages; recurring demand rather than reliance on one-off medical tourists | Geriatric assessment; medication management; nutrition; fall prevention; rehab; medical day care; senior-friendly long-stay; preventive-health retreat | Membership; care packages; long-stay; B2B corporate contracts; management fees | Hanoi and Ho Chi Minh City first; resort cities thereafter. |
Source: B&Company compilation
Vietnam’s opportunity in medical tourism does not lie in replicating a mass-market, low-cost regional model. A more compelling proposition is the combination of demonstrated high-tech clinical capabilities, competitive costs and relatively rapid access with an international service layer that remains underdeveloped. The USD 2–3 billion that Vietnamese patients spend on treatment abroad each year indicates that the target market is not limited to inbound patients; it also includes premium domestic demand that has yet to be retained in Vietnam. [1]
For Japanese companies, a strategic entry point is to address these gaps directly: standardizing quality and data, building an end-to-end patient journey, developing rehabilitation and elderly-care services, and connecting hospitals with medical hotels/recovery residences. This approach allows Japanese companies to create value through operating capabilities and service standards rather than competing primarily on price or immediately investing in a large-scale hospital.
Read more
Medical Tourism from Vietnam: Market Trends, Patient Insights, and Global Opportunities
Sources and Data Notes
[1] VietnamPlus, “Ministry of Health: Making Vietnam a Leading Medical Tourism Destination in the Region” (2026). Figures: 300,000 international users, USD 1–2 billion; outbound spending of USD 2–3 billion; healthcare system scale and 2026–2030 development direction.
[2] VnEconomy, “Vietnam Seizes Opportunities as Medical Tourism Booms in Asia.”
[3] Vietnam National Authority of Tourism, information on medical-tourism product development and service-chain linkages.
[4] Law on Medical Examination and Treatment No. 15/2023/QH15.
[5] Vietnam’s current legal framework on personal-data protection; specific legal review is required for each cross-border data-sharing model.
[6] Ministry of Public Security, information on fraud/clinic-related risks, used in the original document to illustrate reputational risk.
[7] JETRO, Expert Perspectives: Healthtech Ecosystem.
[8] Binh Dan Hospital/VietnamNet/Thanh Nien (2025–2026): American patient with a 15-year urethral stricture; 98% success rate for urethral reconstruction; 1,096 patients from 26 countries treated during 2023–2025.
[9] Tu Du Hospital/VietnamPlus/VnExpress (05–06/2025): fetal cardiac intervention for a Singaporean patient jointly performed by Tu Du Hospital and Children’s Hospital 1.
[10] Ho Chi Minh City Police Newspaper (07/2026), citing deployment data for the Da Vinci Xi system at Tam Anh General Hospital Ho Chi Minh City: cost approximately USD 5,000–7,000, about 30% of the cost of treatment abroad using the same technology. This figure relates to one specific facility and is not representative of the entire market.
[11] T-Matsuoka Medical Center, Ningen Dock health screening and system overview: https://t-matsuoka.com/dich-vu/kiem-tra-suc-khoe-ningen-dock

